These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 20584172)
41. Possible effects of risk factors on fibrinolysis. Kwaan HC Adv Exp Med Biol; 1978; 104():295-300. PubMed ID: 717138 [No Abstract] [Full Text] [Related]
42. MiR-3202 - Promoted H5V Cell Apoptosis by Directly Targeting Fas Apoptotic Inhibitory Molecule 2 (FAIM2) in High Glucose Condition. Huang X; Xie H; Xue G; Ye M; Zhang L Med Sci Monit; 2017 Feb; 23():975-983. PubMed ID: 28228635 [TBL] [Abstract][Full Text] [Related]
43. Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial. Corella D; Sorlí JV; González JI; Ortega C; Fitó M; Bulló M; Martínez-González MA; Ros E; Arós F; Lapetra J; Gómez-Gracia E; Serra-Majem L; Ruiz-Gutierrez V; Fiol M; Coltell O; Vinyoles E; Pintó X; Martí A; Saiz C; Ordovás JM; Estruch R Cardiovasc Diabetol; 2014 Jan; 13():5. PubMed ID: 24393375 [TBL] [Abstract][Full Text] [Related]
44. Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. Tarantino G; Scopacasa F; Colao A; Capone D; Tarantino M; Grimaldi E; Savastano S World J Gastroenterol; 2011 Dec; 17(48):5280-8. PubMed ID: 22219597 [TBL] [Abstract][Full Text] [Related]
45. Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST. Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Hérnandez G; Egido J; Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):168-74. PubMed ID: 17053166 [TBL] [Abstract][Full Text] [Related]
46. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease. Hébert MJ; Masse M; Vigneault N; Sirois I; Troyanov S; Madore F Am J Kidney Dis; 2001 Dec; 38(6):1271-6. PubMed ID: 11728960 [TBL] [Abstract][Full Text] [Related]
47. Cigarette smoking and serum soluble Fas levels: Findings from the JACC study. Tamakoshi A; Suzuki K; Lin Y; Ito Y; Yagyu K; Kikuchi S; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Mutat Res; 2009; 679(1-2):79-83. PubMed ID: 19682600 [TBL] [Abstract][Full Text] [Related]
48. Blood-soluble Fas levels are increased in type 2 diabetic patients with peripheral vascular disease. García-Unzueta MT; Pesquera C; Calzada E; De la Mora A; Muñoz P; Llorca J; Morchón N; Fernández-González MD; Amado JA Horm Metab Res; 2006 Oct; 38(10):673-7. PubMed ID: 17075777 [TBL] [Abstract][Full Text] [Related]
49. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Andreassi MG Mutat Res; 2009 Jul; 667(1-2):35-43. PubMed ID: 19028510 [TBL] [Abstract][Full Text] [Related]